Responses
Clinical/translational cancer immunotherapy
Original research
Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancers
Compose a Response to This Article
Other responses
No responses have been published for this article.
